Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy
Current Neurology and Neuroscience Reports, 05/16/2012
Ryther RCC et al. – Clinical studies of rapamycin in human epilepsy are limited, but suggest that mammalian target of rapamycin (mTOR) inhibitors at least have antiseizure effects in tuberous sclerosis patients.



